TASLY(SH:600535) Zhong Guo Zheng Quan Bao - Zhong Zheng Wang·2025-11-27 02:42Core Viewpoint - The company, Tasly Pharmaceutical Group Co., Ltd., is set to hold a Q3 2025 earnings presentation on December 4, 2025, to discuss its operational results and financial status with investors [2][3]. Group 1: Meeting Details - The earnings presentation will take place on December 4, 2025, from 15:00 to 16:00 [2][6]. - The location for the meeting is the Shanghai Stock Exchange Roadshow Center, accessible online [2][6]. - The meeting will be conducted in an interactive online format, allowing for real-time engagement with investors [3][5]. Group 2: Investor Participation - Investors can submit questions for the presentation from November 27, 2025, to December 3, 2025, by visiting the Roadshow Center's website or via the company's email [2][7]. - The company will address commonly asked questions during the earnings presentation [3][7]. Group 3: Company Representatives - Key representatives from the company include Mr. Cai Jinyong (General Manager), Mr. Yu Jie (Board Secretary), and Ms. Wei Jie (Chief Financial Officer) [4].